Merck Provides Update on Odanacatib Development Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. CHWY
4. USO
5. NAVN
6. SPCX
7. HUMA
8. cASY
9. CME
10. OXM

Go back to Merck Provides Update on Odanacatib Development Program
Merck & Co. (NYSE: MRK) Delayed: 120.93 +1.84 (1.55%)
Previous Close $119.09    52 Week High $65.46 
Open $120.04    52 Week Low $47.97 
Day High $121.20    P/E 82.27 
Day Low $119.95    EPS $1.47 
Volume 1,922,733